1. Immunological Prognostic Factors in Multiple Myeloma
   Dominika Bębnowska et al, 2021, International Journal of Molecular Sciences CrossRef
2. Association between interleukin-1 receptor polymorphism and human herpesvirus 8 among lymphoma patients
   Ameer J Abbas Al-Jawdhari et al, 2023, Medical Journal of Babylon CrossRef
3. Role of cytokines in multiple myeloma: IL-1RN and IL-4 VNTR polymorphisms
   Istemi Serin et al, 2022, Cytokine CrossRef
4. Spon1+ inflammatory monocytes promote collagen remodeling and lung cancer metastasis through lipoprotein receptor 8 signaling
   Kristina M. Whately et al, 2024, JCI Insight CrossRef
5. The Role of Interleukin-1 in the Pathogenesis of Cancer and its Potential as a Therapeutic Target in Clinical Practice
   Adi Litmanovich et al, 2018, Oncology and Therapy CrossRef
6. Role of Interleukin-1 in the pathogenesis of colorectal cancer: A brief look at anakinra therapy
   Jun Xie et al, 2022, International Immunopharmacology CrossRef
7. Positive correlation between interleukin-1 receptor antagonist gene 86bp VNTR polymorphism and colorectal cancer susceptibility: a case-control study
   Mostafa Ibrahimi et al, 2019, Immunologic Research CrossRef
8. KANSER GELİŞİMİNDE İNFLAMASYONUN ROLÜ
   Işıl Yıldırım, 2019, ANADOLU UNIVERSITY JOURNAL OF SCIENCE AND TECHNOLOGY –C Life Sciences and Biotechnology CrossRef
9. Strategies to overcome interleukin-1-mediated immune suppression and resistance to immunotherapy in cancer
   Abhishek Puthenveetil et al, 2023, Multifaceted Role of IL-1 in Cancer and Inflammation CrossRef
10. Laboratory biomarkers of an effective antitumor immune response. Clinical significance.
    A.M. Malkova et al, 2021, Cancer Treatment and Research Communications CrossRef